22
Views
11
CrossRef citations to date
0
Altmetric
Hyperthermic Intraperitoneal Chemotherapy

Adjuvant Hyperthermic Intraperitoneal Peroperative Chemotherapy (HIPEC) Associated with Curative Surgery for Locally Advanced Gastric Carcinoma. An Initial Experience

, , , , , , & show all
Pages 297-301 | Published online: 11 Mar 2016

References

  • Siewert J. R., Fink U., Sendler A. et al. Gastric cancer. Curr Probl Surg, 1997, 34: 835–939.
  • Schwartz R. E., Zagala-Nevarez K. Recurrence patterns after radical gastrectomy for gastric cancer. Prognostic factors and implications for postoperative adjuvant therapy. Ann Surg Oncol, 2002, 9: 394–400.
  • Roviello F., Marrelli D., de Manzoni G. et al. Italian Research Group for Gastric Cancer. Prospective study of peritoneal recurrence after curative surgery for gastric cancer. Br J Surg, 2003, 90: 1113–9.
  • Sugarbaker P. H., Yu W., Yonemura Y. Gastrectomy, peritonecto-my and perioperative intraperitoneal chemotherapy: the evolution of treatment strategies for advanced gastric cancer. Sem Surg Oncol, 2003, 21: 233–248.
  • Detroz B., Laurent S., Honoré P. et al. Rationale for hyperther-mic intraperitoneal chemotherapy (HiPEC) in the treatment or prevention of peritoneal carcinomatosis. Acta Chir Belg, 2004, 104: 377–383.
  • UICC. International Union Against Cancer, TNM. Classification of malignant tumours. In: Sobin L. H., Wittekind C. (eds). New York: wiley-Liss, 2002.
  • Koga S., Hamazoe R., Maeta M. et al. Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperther-mic peritoneal perfusion with mitomycin C. Cancer, 1988, 61: 232–237.
  • Fujimoto S., Takahashi M., Mutou T. et al. Successful intraperi-toneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma. Cancer, 1999, 85: 529–34.
  • Yonemura Y., de Aretxabala X., Fujimura T. et al. Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled study. Hepato-gastroenterology, 2001, 48: 1776–82.
  • Huang Y., Hagiwara A., Wang W. et al. Local injection of M-CH combined with i.p. hyperthermic hypo-osmolar infusion is an effective therapy in advanced gastric cancer. Anticancer Drugs, 2002, 13: 431–35.
  • Hamazoe R., Maeta M., Kaibara N. Intraperitoneal ther-mochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study. Cancer, 1994, 73: 2048–52.
  • Ikeguchi M., Kondou A., Oka A. et al. Effects of continuous hyperthermic peritoneal perfusion on prognosis of gastric cancer with serosal invasion. Eur J Surg, 1995, 161: 581–6.
  • Stephens A. D., Alderman R., Chang D. et al. Morbidity and mortality analysis of, 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol, 1999, 6: 790–6.
  • Walker M. J. A review of carcinoma of the stomach at a tertiary care referral hospital. Am J Surg, 1996, 172: 75–78.
  • Bozzetti F., Bignami P., Bertarion L. et al. Surgical treatment of gastric cancer invading the oesophagus. Eur J Surg Oncol, 2000, 26: 810–4.
  • MacDonald J. S., Smalley S. R., Benedetti J. et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med, 2001, 345: 725–30.
  • Bonenkamp J. J., Hermans J., Sasako M. et al. Extended lymph-node dissection for gastric cancer. Dutch Gastric Cancer Group. NEngl J Med, 1999, 340: 908–14.
  • Cuschieri A., Weeden S., Fielding J. Patient survival after D1 and D2 resections for gastric cancer: long term results of the MRC randomized surgical trial. Br J Cancer, 1999, 79: 1522–30.
  • Siewert J. R., Böttcher K., Stein H. J. et al. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg, 1998, 228: 449–61.
  • Bando E., Yonemura Y., Takeshita Y. Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinoma. Am J Surg, 1999, 178: 256–62.
  • Barlogie B., Corry P. M., Drewinko B. In vitro ther-mochemotherapy of human colon cancer cells with cis-dichloro-diammineplatinum(ii) and mitomycin C. Cancer Res, 1980, 40: 1165–8.
  • Teicher B. A., Kowal C. D., Kennedy K. A. et al. Enhancement by hyperthermia of the in vitro cytotoxicity of mitomycin C toward hypoxic tumor cells. Cancer Res, 1981, 41: 1069–1099.
  • Pestieau S. R., Belliveau J. F., Griffin H. et al. Pharmacokinetics of intraperitoneal oxaliplatin. J Surg Oncol, 2001, 76: 106–14.
  • Jacquet P., Averbach A., Stephens A. D. et al. Heated intraoperative intraperitoneal mitomycin C and early postoperative intraperi-toneal 5-fluorouracil: pharmacokinetic studies. Oncology, 1998, 55: 130–8.
  • Sadeghi B., Arvieux C., Glehen O. et al. Peritoneal Carcinomatosis from non-gynecologic malignancies: results of the EvoCAPE 1 multicentic prospective study. Cancer, 2000, 88: 358–63.
  • Midgley R., Kerr D. Colorectal cancer. Lancet, 1999, 353: 391–99.
  • Elias D., Blot F., El Otmany A. et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer, 2001, 92: 71–76.
  • Verwaal V. J., van Ruth S., de Bree E. et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol, 2003, 21: 3737–43.
  • Sayag-Beaujard A. C., Francois Y., Glehen O. et al. Intraperitoneal chemo-hyperthermia with mitomycin C for gastric cancer patients with peritoneal carcinomatosis. Anticancer Res, 1999, 19: 1375–82.
  • Yonemura Y., Fujimura T., Nishimura G. et al. Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination. Surgery, 1996, 119: 437–44.
  • Elias D., Antoun S., Raynard B. et al. Treatment of peritoneal carcinomatosis using complete excision and intraperitoneal chemohyperthermia. A phase i-ii study defining the best technical procedures. Chirurgie, 1999, 124: 380–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.